A detailed history of Sivik Global Healthcare LLC transactions in Repligen Corp stock. As of the latest transaction made, Sivik Global Healthcare LLC holds 25,000 shares of RGEN stock, worth $3.56 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares
25,000
Previous 15,000 66.67%
Holding current value
$3.56 Million
Previous $1.89 Million 96.77%
% of portfolio
1.58%
Previous 0.68%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$119.79 - $167.35 $1.2 Million - $1.67 Million
10,000 Added 66.67%
25,000 $3.72 Million
Q2 2024

Jul 29, 2024

BUY
$120.0 - $182.95 $1.8 Million - $2.74 Million
15,000 New
15,000 $1.89 Million
Q1 2021

May 12, 2021

SELL
$180.37 - $226.26 $2.71 Million - $3.39 Million
-15,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$148.08 - $206.57 $2.22 Million - $3.1 Million
15,000 New
15,000 $2.87 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.91B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Sivik Global Healthcare LLC Portfolio

Follow Sivik Global Healthcare LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.